Author
Listed:
- Timothy J. Aitman
(Molecular Medicine Group, MRC Clinical Sciences Centre, and Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital)
- Lisa D. Cooper
(Molecular Medicine Group, MRC Clinical Sciences Centre, and Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital)
- Penny J. Norsworthy
(Molecular Medicine Group, MRC Clinical Sciences Centre, and Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital)
- Faisal N. Wahid
(Molecular Medicine Group, MRC Clinical Sciences Centre, and Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital)
- Jennefer K. Gray
(Molecular Medicine Group, MRC Clinical Sciences Centre, and Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital)
- Brian R. Curtis
(Blood Center of Southeastern Wisconsin, Medical College of Wisconsin)
- Paul M McKeigue
(London School of Hygiene and Tropical Medicine)
- Dominic Kwiatkowski
(MRC Laboratories)
- Brian M. Greenwood
(MRC Laboratories)
- Robert W. Snow
(KEMRI Coastal Research Unit)
- Adrian V Hill
(Wellcome Trust Centre for Human Genetics, University of Oxford)
- James Scott
(Molecular Medicine Group, MRC Clinical Sciences Centre, and Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital)
Abstract
A critical step in infection by Plasmodium falciparum, the microorganism that causes the most severe form of malaria, is the adhesion of parasitized red blood cells to capillary endothelium. The human protein CD36 is a major receptor for P. falciparum-infected red blood cells1,2 and may contribute to the disease by sequestering infected red blood cells1,2 and inhibiting the immune response to the parasite3. We have found that African populations contain an exceptionally high frequency of mutations in CD36. Unexpectedly, these mutations that cause CD36 deficiency are associated with susceptibility to severe malaria, suggesting that the presence of distinct CD36 mutations in Africans and Asians4,5,6 is due to some selection pressure other than malaria.
Suggested Citation
Timothy J. Aitman & Lisa D. Cooper & Penny J. Norsworthy & Faisal N. Wahid & Jennefer K. Gray & Brian R. Curtis & Paul M McKeigue & Dominic Kwiatkowski & Brian M. Greenwood & Robert W. Snow & Adrian V, 2000.
"Malaria susceptibility and CD36 mutation,"
Nature, Nature, vol. 405(6790), pages 1015-1016, June.
Handle:
RePEc:nat:nature:v:405:y:2000:i:6790:d:10.1038_35016636
DOI: 10.1038/35016636
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:405:y:2000:i:6790:d:10.1038_35016636. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.